Biomarkers in cancer

Articles in the same Issue

1. Frontmatter
2. Committees
3. Contents
4. Speakers Abstracts
5. Educational Workshop Abstracts
6. Advanced technologies, including new biomarker discovery
7. Analytical technologies and applications
8. Artificial intelligence - Informatics
9. Atherosclerosis, including lipids and other risk markers
10. Audit
11. Autoimmune diseases , including allergy
12. Bioinformatics, including data management
13. Biomarkers in cancer
14. Bone metabolism
15. Cardiovascular diseases, including cardiac markers
16. Case report
17. Clinical Studies - Outcomes
18. Diabetes, obesity, metabolic syndrome
19. Education and Training in Laboratory Medicine
20. Endocrinology, not including diabetes
21. Evidence based medicine, including Guidelines
22. Gastrointestinal diseases, including hepatic and pancreatic diseases
23. Genetic diseases
24. Haematology, including haemostasis
25. Inflammation, vascular biology, endothelium, and oxidative stress
26. Inherited disorders, metabolic disorders and rare diseases
27. Kidney diseases
28. Laboratory and Sports medicine
29. Laboratory Management, Accreditation, Quality Assurance, performance specification
30. Microbiology - Infectious diseases including COVID 19
31. Molecular diagnostics, including epigenetics
32. Neonatal and paediatric laboratory medicine, including prenatal testing
33. Neurological diseases
34. Nutrition, including vitamins and trace elements
35. Other
36. Personalised Medicine, including pharmacogenetics
37. Point of Care testing, critical care, emergency medicine.
38. Reference intervals and decision limits
39. Total Testing Process, including standardisation, preanalytical process
40. Toxicology, including therapeutic drug monitoring
41. Urinalysis